Expression of Five Somatostatin Receptor MRNAs in the Human Brain and Pituitary

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1996 Oct 1

PMID 8897442

Citations 15

Authors

V S Thoss

J Perez

A Probst

D Hoyer

Affiliations

Soon will be listed here.

Abstract

The messenger RNA (mRNA) expression of somatostatin receptors sst1-5 was studied in human brain by in situ hybridization histochemistry using specific oligonucleotide probes. sst1 receptor mRNA was mainly found in the outer and intermediate layers of cerebral cortex, hippocampal formation (CA1, dentate gyrus, entorhinal cortex), hypothalamus, substantia nigra, medullary nuclei and dentate nucleus. sst2 transcripts were present in the deep layers of the cerebral cortex, amygdala, hippocampal formation (CA1, dentate gyrus, subiculum, entorhinal cortex), the granular layer of the cerebellum and pituitary. sst3 receptor mRNA was localized in the cerebral cortex, hippocampal formation (CA1, dentate gyrus), several medullary nuclei and the granule and possibly Purkinje cell layer of the cerebellum and at very low levels in the pituitary. sst4 receptor mRNA was absent in the cerebral cortex. Intermediate signals were observed in the dentate gyrus of the hippocampus and several medullary nuclei while an intense expression was found in the granule and Purkinje cell layer of cerebellum. sst5 transcripts were present in the pituitary and the granule layer of the cerebellum. The present results show that mRNAs of sst1-4 somatostatin receptors have distinct distribution patterns within the human brain, although there is overlap in several regions. sst5 receptor mRNA expression appears to be very low and restricted to the cerebellum and pituitary. The distribution pattern observed in the human brain was broadly similar to that reported previously in the rat brain. The high expression levels of at least two somatostatin receptor subtype mRNAs (sst2 and sst5) in the pituitary gland suggest that somatostatin may affect neuroendocrine functions via more than one receptor.

Citing Articles

Chrono-Endocrinology in Clinical Practice: A Journey from Pathophysiological to Therapeutic Aspects.

Mercadante S, Bellastella A Life (Basel). 2024; 14(5).

PMID: 38792568 PMC: 11121809. DOI: 10.3390/life14050546.

SSTR2 Mediates the Inhibitory Effect of SST/CST on Lipolysis in Chicken Adipose Tissue.

Zhang X, Zhang J, Huang T, Wang X, Su J, He J Animals (Basel). 2024; 14(7).

PMID: 38612272 PMC: 11010918. DOI: 10.3390/ani14071034.

The Organization of Somatostatin-Immunoreactive Cells in the Visual Cortex of the Gerbil.

Kwon K, Lee M, Chung H, Pak J, Jeon C Biomedicines. 2022; 10(1).

PMID: 35052772 PMC: 8773527. DOI: 10.3390/biomedicines10010092.

Chronothyroidology: Chronobiological Aspects in Thyroid Function and Diseases.

Bellastella G, Maiorino M, Scappaticcio L, De Bellis A, Mercadante S, Esposito K Life (Basel). 2021; 11(5).

PMID: 34068480 PMC: 8151474. DOI: 10.3390/life11050426.

A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Robinson S, Thiele T Neuropharmacology. 2020; 167:107983.

PMID: 32027909 PMC: 7080567. DOI: 10.1016/j.neuropharm.2020.107983.

References

Perez J, Vezzani A, Civenni G, Tutka P, Rizzi M, Schupbach E . Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience. 1995; 65(4):1087-97. DOI: 10.1016/0306-4522(94)00535-d. View

Whitford C, Candy J, Bloxham C, Oakley A, Snell C . Human cerebellar cortex possesses high affinity binding sites for [3H]somatostatin. Eur J Pharmacol. 1985; 113(1):129-32. DOI: 10.1016/0014-2999(85)90353-x. View

Whitford C, Bloxham C, Snell C, Candy J, Hirst B . Regional distribution of high-affinity [3H]somatostatin binding sites in the human brain. Brain Res. 1986; 398(1):141-7. DOI: 10.1016/0006-8993(86)91259-x. View

Beal M, Mazurek M, Tran V, Chattha G, BIRD E, Martin J . Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science. 1985; 229(4710):289-91. DOI: 10.1126/science.2861661. View

Hoyer D, Bell G, Berelowitz M, Epelbaum J, Feniuk W, Humphrey P . Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995; 16(3):86-8. DOI: 10.1016/s0165-6147(00)88988-9. View

Kluxen F, Bruns C, Lubbert H . Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci U S A. 1992; 89(10):4618-22. PMC: 49134. DOI: 10.1073/pnas.89.10.4618. View

Cooper P, Fernstrom M, Rorstad O, Leeman S, Martin J . The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res. 1981; 218(1-2):219-32. DOI: 10.1016/0006-8993(81)91302-0. View

Nemeroff C, Youngblood W, Manberg P, Prange Jr A, Kizer J . Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science. 1983; 221(4614):972-5. DOI: 10.1126/science.6136092. View

Laquerriere A, Leroux P, Gonzalez B, Bodenant C, TAYOT J, Vaudry H . Somatostatin receptors in the human cerebellum during development. Brain Res. 1992; 573(2):251-9. DOI: 10.1016/0006-8993(92)90770-a. View

10.

Thoss V, Piwko C, Hoyer D . Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization. Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(6):648-60. DOI: 10.1007/BF00167184. View

11.

Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y . Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun. 1993; 195(2):844-52. DOI: 10.1006/bbrc.1993.2122. View

12.

Wulfsen I, Meyerhof W, Fehr S, Richter D . Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary. J Neurochem. 1993; 61(4):1549-52. DOI: 10.1111/j.1471-4159.1993.tb13654.x. View

13.

Bakst I, Morrison J, Amaral D . The distribution of somatostatin-like immunoreactivity in the monkey hippocampal formation. J Comp Neurol. 1985; 236(4):423-42. DOI: 10.1002/cne.902360402. View

14.

Chessell I, Black M, Feniuk W, Humphrey P . Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones. Br J Pharmacol. 1996; 117(8):1673-8. PMC: 1909561. DOI: 10.1111/j.1476-5381.1996.tb15338.x. View

15.

Thoss V, Perez J, Duc D, Hoyer D . Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology. 1995; 34(12):1673-88. DOI: 10.1016/0028-3908(95)00135-2. View

16.

Schindler M, Harrington K, Humphrey P, Emson P . Cellular localisation and co-expression of somatostatin receptor messenger RNAs in the human brain. Brain Res Mol Brain Res. 1995; 34(2):321-6. DOI: 10.1016/0169-328x(95)00191-t. View

17.

Beal M, Benoit R, BIRD E, Martin J . Immunoreactive somatostatin-28(1-12) is increased in Huntington's disease. Neurosci Lett. 1985; 56(3):377-80. DOI: 10.1016/0304-3940(85)90272-1. View

18.

Yamada Y, Reisine T, Law S, Ihara Y, Kubota A, Kagimoto S . Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol. 1992; 6(12):2136-42. DOI: 10.1210/mend.6.12.1337145. View

19.

Hoyer D, Lubbert H, Bruns C . Molecular pharmacology of somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol. 1994; 350(5):441-53. DOI: 10.1007/BF00173012. View

20.

Senaris R, Humphrey P, Emson P . Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary. Eur J Neurosci. 1994; 6(12):1883-96. DOI: 10.1111/j.1460-9568.1994.tb00579.x. View